Smith & Nephew (SNN) Given “Buy” Rating at Canaccord Genuity

Canaccord Genuity reaffirmed their buy rating on shares of Smith & Nephew (NYSE:SNN) in a report issued on Thursday, Marketbeat reports.

Other equities analysts have also issued reports about the stock. UBS Group lowered shares of Smith & Nephew from a buy rating to a neutral rating in a research report on Wednesday, August 8th. Zacks Investment Research raised shares of Smith & Nephew from a sell rating to a hold rating in a research report on Tuesday, August 7th. Finally, HSBC lowered shares of Smith & Nephew from a buy rating to a hold rating in a research report on Tuesday, October 16th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the stock. Smith & Nephew has an average rating of Hold and an average target price of $41.00.

SNN traded up $0.69 during trading on Thursday, reaching $36.21. 1,459,800 shares of the company’s stock were exchanged, compared to its average volume of 622,222. Smith & Nephew has a 1 year low of $32.22 and a 1 year high of $39.85. The company has a current ratio of 2.13, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The firm has a market capitalization of $14.28 billion, a PE ratio of 19.06, a P/E/G ratio of 2.69 and a beta of 0.47.

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Checchi Capital Advisers LLC purchased a new position in shares of Smith & Nephew during the 2nd quarter valued at approximately $204,000. Capital Fund Management S.A. purchased a new position in shares of Smith & Nephew during the 2nd quarter valued at approximately $210,000. Avestar Capital LLC increased its holdings in shares of Smith & Nephew by 25.8% during the 3rd quarter. Avestar Capital LLC now owns 7,910 shares of the medical equipment provider’s stock valued at $276,000 after purchasing an additional 1,623 shares in the last quarter. Alps Advisors Inc. purchased a new position in shares of Smith & Nephew during the 2nd quarter valued at approximately $302,000. Finally, SG Americas Securities LLC purchased a new position in shares of Smith & Nephew during the 2nd quarter valued at approximately $372,000. 8.70% of the stock is owned by institutional investors.

About Smith & Nephew

Smith & Nephew plc designs, develops, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder.

Featured Story: Market Capitalization

Analyst Recommendations for Smith & Nephew (NYSE:SNN)

Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply